Skip to main content
. 2018 Apr-Jun;13(2):370–374. doi: 10.4103/ajns.AJNS_174_16

Figure 3.

Figure 3

Comparison of the recurrence period of chronic subdural hematoma. Recurrence period was significantly longer in the goreisan-administered group (A + B) than that in the group that was not administered any drug (C)